ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each

June 11, 1982

NCI Programs: Contract Awarded For Geographic Information System

May 14, 1999